Semi-quantitative analysis of rheumatoid finger joint synovitis using power Doppler ultrasonography: When to perform follow-up study after treatment consisting mainly of antitumor necrosis factor alpha agent

Skeletal Radiology

Volumn 39, Issue 5, 2010, Pages 457-465

  Kamishima, Tamotsu ^a   Sagawa, Akira ^b   Tanimura, Kazuhide ^c   Shimizu, Masato ^c   Matsuhashi, Megumi ^c   Shinohara, Masahide ^d   Hagiwara, Hiromi ^c   Henmi, Mihoko ^c   Narita, Akihiro ^c   Terae, Satoshi ^a   Shirato, Hiroki ^a  

^a HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^b Sagawa Akira Rheumatology Clinic   (Japan)

^c Nishimura Hospital   (Japan)

^d NTT CORPORATION   (Japan)

Author keywords

Antitumor necrosis factor alpha; Power Doppler ultrasonography; Rheumatoid arthritis; Synovitis

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; INFLIXIMAB; METHOTREXATE;

ADULT; AGED; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DOPPLER ECHOGRAPHY; DRUG INFUSION; DRUG RESPONSE; FEMALE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; MALE; METACARPOPHALANGEAL JOINT; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SYNOVITIS; TREATMENT DURATION;

ADULT; AGED; ALGORITHMS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; FINGER JOINT; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYNOVITIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY, DOPPLER;

EID: 77952544132     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-009-0824-5     Document Type: Article

References (35)

1. American College of Rheumatology ad hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 1996; 39: 713-722
2. Martel W. Radiologic manifestations of rheumatoid arthritis with particular reference to the hand, wrist and foot. Med Clin North Am. 1968; 52: 655-665
3. Klarlund M, Ostergaard M, Lorenzen I. Finger joint synovitis in rheumatoid arthritis: quantitative assessment by magnetic resonance imaging. Rheumatology (Oxford). 1999; 38: 66-72.
4. Konig H, Bolze X, Sieper J, Wolf KJ. Quantitatively evaluated dynamic magnetic resonance tomography in chronic polyarthritis of the knee joint. A therapeutic follow-up after intra-articular cortisone application. Rofo Fortschr Geb Rontgenstr Neuen BildgebVerfahr. 1992; 157: 140-144
5. Fornage BD. Soft-tissue changes in the hand in rheumatoid arthritis: evaluation with US. Radiology. 1989; 173: 735-737
6. Newman JS, Adler RS, Bude RO, Rubin JM. Detection of softtissue hyperemia: value of power Doppler sonography. AJR Am J Roentgenol. 1994; 163: 385-389
7. Newman JS, Laing TJ, McCarthy CJ, Adler RS. Power Doppler sonography of synovitis: assessment of therapeutic response-preliminary observations. Radiology. 1996; 198: 582-584
8. Walther M, Harms H, Krenn V, Radke S, Faehndrich TP, Gohlke F. Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 2001; 44: 331-338
9. Grassi W, Filippucci E. Is power Doppler sonography the new frontier in therapy monitoring? Clin Exp Rheumatol. 2003; 21: 424-428
10. Filippucci E, Farina A, Cervini C,GrassiW. Juvenile chronic arthritis and imaging: comparison of different techniques. Reumatismo. 2001; 53: 63-67
11. Hau M, Kneitz C, Tony HP, Keberle M, Jahns R, Jenett M. High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis receiving treatment with soluble tumour necrosis factor alpha receptor (etanercept). Ann Rheum Dis. 2002; 61: 55-58
12. Taylor PC, Steuer A, Gruber J, Cosgrove DO, Blomley MJ, Marsters PA, et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 2004; 50: 1107-1116
13. Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, Bonnet V, et al. Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factoralpha treatment: pilot study. Radiology. 2003; 229: 562-569
14. Stone M, Bergin D, Whelan B, Maher M, Murray J, McCarthy C. Power Doppler ultrasound assessment of rheumatoid hand synovitis. J Rheumatol. 2001; 28: 1979-1982
15. Teh J, Stevens K, Williamson L, Leung J, McNally EG. Power Doppler ultrasound of rheumatoid synovitis: quantification of therapeutic response. Br J Radiol. 2003; 76: 875-879
16. Terslev L, Torp-Pedersen S, Qvistgaard E, Danneskiold-Samsoe B, Bliddal H. Estimation of inflammation by Doppler ultrasound: quantitative changes after intra-articular treatment in rheumatoid arthritis. Ann Rheum Dis. 2003; 62: 1049-1053
17. Terslev L, Torp-Pedersen S, Qvistgaard E, Kristoffersen H, Rogind H, Danneskiold-Samsoe B, et al. Effects of treatment with etanercept (Enbrel, TNRF:Fc) on rheumatoid arthritis evaluated by Doppler ultrasonography. Ann Rheum Dis. 2003; 62: 178-181
18. Filippucci E, Farina A, Carotti M, Salaffi F, Grassi W. Grey scale and power Doppler sonographic changes induced by intra-articular steroid injection treatment. Ann Rheum Dis. 2004; 63: 740-743
19. Naredo E, Collado P, Cruz A, Palop MJ, Cabero F, Richi P, et al. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Rheum. 2007; 57: 116-124
20. Wakefield RJ, Freeston JE, Hensor EM, Bryer D, Quinn MA, Emery P. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis. Arthritis Rheum. 2007; 57: 1564-1567
21. MacGregor AJ. Classification criteria for rheumatoid arthritis. Baillieres Clin Rheumatol. 1995; 9: 287-304.
22. Miyasaka N, Takeuchi T, Eguchi K. Proposed [corrected] Japanese guidelines for the use of infliximab for rheumatoid arthritis. Mod Rheumatol. 2005; 15: 4-8.
23. Smolen JS, Breedveld FC, Eberl G, Jones I, Leeming M, Wylie GL, et al. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum. 1995; 38: 38-43.
24. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980; 23: 137-145
25. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. 1993; 20: 579-581
26. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993; 36: 729-740
27. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995; 38: 727-735
28. Felson DT, Anderson JJ, Lange ML, Wells G, LaValley MP. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum. 1998; 41: 1564-1570
29. Kamishima T, Tanimura K, Henmi M, Narita A, Sakamoto F, Terae S, et al. Power Doppler ultrasound of rheumatoid synovitis: quantification of vascular signal and analysis of interobserver variability. Skeletal Radiol. 2009; 38: 467-472
30. Naredo E, RodriguezM, Campos C, Rodriguez-Heredia JM,Medina JA, Giner E, et al. Validity, reproducibility, and responsiveness of a twelve-joint simplified power Doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2008; 59: 515-522
31. Kasukawa R, Shio K, Kanno Y, Sato A, Takahashi A, Yamadera Y, et al. Power Doppler and spectral Doppler measurements of knee-joint synovitis in rheumatoid arthritis patients with superficial pattern signals and in those with deep pattern signals. Mod Rheumatol. 2007; 17: 267-272
32. Schueller-Weidekamm C, Krestan C, Schueller G, Kapral T, Aletaha D, Kainberger F. Power Doppler sonography and pulseinversion harmonic imaging in evaluation of rheumatoid arthritis synovitis. AJR Am J Roentgenol. 2007; 188: 504-508
33. Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis. 2005; 64: 375-381
34. Naredo E, Moller I, Moragues C, de Agustin JJ, Scheel AK, Grassi W, et al. Interobserver reliability in musculoskeletal ultrasonography: results from a "Teach the Teachers" rheumatologist course. Ann Rheum Dis. 2006; 65: 14-19
35. Fiocco U, Ferro F, Vezzu M, Cozzi L, Checchetto C, Sfriso P, et al. Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept. Ann Rheum Dis. 2005; 64: 899-905.